CSOP Hang Seng Biotech ETF (03174.HK) rose 0.80%, with the latest price at HKD 3.548
Newtimespace News：As of the close on April 28, the CSOP Hang Seng Biotech ETF (03174.HK) rose 0.80%, with the latest price at HKD 3.548 and assets under management of approximately HKD 891 million.
Newtimespace News：As of the close on April 28, the CSOP Hang Seng Biotech ETF (03174.HK) rose 0.80%, with the latest price at HKD 3.548, a high of HKD 3.632, a low of HKD 3.508, an average price of HKD 3.547, assets under management of approximately HKD 891 million, a latest net asset value of HKD 3.518, and a premium of 0.07%.
The CSOP Hang Seng Biotech ETF (03174.HK) tracks the Hang Seng Biotech Index, which consists of listed companies in biotech, pharmaceuticals, and healthcare sectors in Hong Kong, reflecting the overall performance of Hong Kong's biotech sector.
Tags：
- Mabwell(02493.HK) Elects Dr. Gui Xun as Employee Representative Director
- Ruixin International Group (00724.HK): Delisting to Take Effect from June 23
- Far East Horizon (03360.HK): Update of US$4 Billion Medium-Term Note and Perpetual Securities Programme
- Asia Allied Infrastructure (00711.HK): Positive Profit Alert, Expected Annual Profit of Not Less Than HK$120 Million
- Huaneng Power International, Inc. (00902.HK): Completes Issuance of RMB 2 Billion Medium-Term Notes with a Coupon Rate of 1.70%
